Medicine by Design announces new strategic plan to advance regenerative medicine and transform healthcare globally
Community collaboration drove the new commitments in bold five-year plan
Community collaboration drove the new commitments in bold five-year plan
Matthew Buechler recently joined the Department of Immunology as an assistant professor.
Two new advisors with decades of industry experience join the program as advisors.
Strategic partnership focuses on training the next generation of leaders, scientists and entrepreneurs.
The conference brought together entrepreneurs, academics, investors and policymakers.
Research grants awarded to products that could impact cancer and rare genetic diseases.
Research reveals a potential way to tailor acute myeloid leukemia (AML) therapies to individual patients.
Trainee-led teams will pitch their ideas in front of expert judges for the chance to receive one of two research funding grants.
The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.
New research sheds light on the role of monocytes.
New research is a step forward to cell therapies for liver disease
Program to fully fund summer positions in Medicine by Design labs beginning in summer 2022.
Catalyst Grants co-awarded to research projects that hold promise in strengthening the connection between data science innovation and regenerative medicine.
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Projects to impact autoimmune, intestinal and degenerative eye diseases